The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Online patient and caregiver conversations focused on neuroendocrine neoplasms (NENs): A global thematic analysis.
 
Udhayvir Grewal
No Relationships to Disclose
 
Jamie Doggett
No Relationships to Disclose
 
Tao Xu
No Relationships to Disclose
 
Mats van Rooij
No Relationships to Disclose
 
Matthew Gao
No Relationships to Disclose
 
Lisa Yen
Honoraria - Curium Pharma; Exelixis; RayzeBio; RayzeBio (I)
Consulting or Advisory Role - Atheneum; Curium Pharma; Exelixis
Travel, Accommodations, Expenses - AtomVie; AtomVie (I); Exelixis; RayzeBio; RayzeBio (I)
 
Josh Mailman
Stock and Other Ownership Interests - Abbott Laboratories; Anthem; AstraZeneca; DANAHER; Dexcom; LabCorp; Medtronic; Novo Nordisk; Sanofi; Thermo Fisher Scientific; Veeva Systems
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Camurus; Curium Pharma; ITM Oncologics
Travel, Accommodations, Expenses - Camurus; Novartis
 
Po Ear
No Relationships to Disclose
 
Chandrikha Chandrasekharan
Honoraria - Tersera
Consulting or Advisory Role - Curium Pharma; Exelixis
 
Seth Concors
No Relationships to Disclose
 
Julie Hallet
Honoraria - Ipsen
Travel, Accommodations, Expenses - Ipsen
 
Andrew Bellizzi
No Relationships to Disclose
 
Emil Lou
Stock and Other Ownership Interests - Ryght
Honoraria - Boston Scientific; Colorectal Cancer Alliance; Daiichi Sankyo/UCB Japan (Inst); GlaxoSmithKline; Novocure
Consulting or Advisory Role - Boston Scientific; Novocure; Novocure; Novocure; Novocure
Research Funding - Intima; Novocure
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences; Minnetronix Medical; NomoCan
 
Michael O'Rorke
No Relationships to Disclose
 
Daniel Halperin
Consulting or Advisory Role - Abbvie; Amryt Pharma; Boehringer Ingelheim; Camurus; Chimeric Therapeutics; Crinetics Pharmaceuticals; Exelixis; Harbour BioMed; Harpoon therapeutics; Ipsen; Isotopen Technologien; Lantheus Medical Imaging; Novartis; Progenics; Radiomedix; Sanofi Aventis GmbH; Tersera
Research Funding - Advanced Accelerator Applications (Inst); Camurus (Inst); Chimeric Therapeutics (Inst); Crinetics Pharmaceuticals (Inst); Genentech/Roche (Inst); Isotopen Technologien (Inst); RayzeBio (Inst); Tarveda Therapeutics (Inst); Thermo Fisher Scientific (Inst)